Related Experiment Video
Updated: Apr 20, 2026
09:44
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
3.5K
Polycystic ovarian syndrome
1Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington Medical Center, 4245 Roosevelt Way Northeast, Seattle, WA 98105, USA.
The Medical Clinics of North America
|December 3, 2014
Summary
Polycystic ovary syndrome (PCOS) involves anovulation, hyperandrogenism, and metabolic issues, increasing diabetes risk. Future research should explore PCOS causes for better prevention and treatment strategies.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Metabolic Health
Background:
- Polycystic ovary syndrome (PCOS) is characterized by chronic anovulation, hyperandrogenism, and metabolic abnormalities.
- The NIH-endorsed Rotterdam criteria facilitate the identification of diverse PCOS phenotypes.
- PCOS is frequently associated with obesity and insulin resistance, elevating risks for glucose intolerance and type 2 diabetes.
Purpose of the Study:
- To summarize the key features and diagnostic criteria of PCOS.
- To highlight the metabolic complications associated with PCOS, particularly insulin resistance and diabetes susceptibility.
- To emphasize the need for future research into the underlying determinants of PCOS.
Main Methods:
- Review of current literature on PCOS diagnosis and associated conditions.
- Analysis of the relationship between PCOS, obesity, insulin resistance, and diabetes.
- Identification of research gaps in understanding PCOS etiology.
Main Results:
- PCOS presents with a spectrum of symptoms including anovulation and hyperandrogenism.
- Obesity and insulin resistance are common in PCOS, leading to increased risk of type 2 diabetes.
- The Rotterdam criteria provide a framework for diagnosing various PCOS phenotypes.
Conclusions:
- PCOS requires comprehensive management due to its anovulatory and metabolic consequences.
- Further investigation into genetic, epigenetic, and environmental factors is crucial for PCOS prevention.
- Developing novel therapeutic approaches is essential to mitigate the long-term complications of PCOS.
Related Concept Videos
01:27Ovarian Cycle
5.8K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
5.8K
01:24Disorders of the Female Reproductive System
4.9K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.9K
02:07Oogenesis
71.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
71.8K
01:22Oogenesis
5.3K
Oogenesis, the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
5.3K
01:30Hormonal Control of the Ovarian Cycle
7.9K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
7.9K
01:19Cushing Syndrome II: Pathophysiology
1
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
1